You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 1, January 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Diagnosis
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lymphomatoid Keratosis

An Epidermotropic Type of Cutaneous Lymphoid Hyperplasia: Clinicopathological, Immunohistochemical, and Molecular Biological Study of 6 Cases

Eiichi Arai, MD; Michio Shimizu, MD; Tetsuya Tsuchida, MD; Seiichi Izaki, MD; Fumihiro Ogawa, MD; Takanori Hirose, MD

Arch Dermatol. 2007;143(1):53-59.

Objective  To provide evidence that lymphomatoid keratosis should be categorized as an epidermotropic subtype of cutaneous lymphoid hyperplasia.

Design  Clinicopathological, immunohistochemical, and molecular biological studies of epidermotropic and dermal bandlike infiltrates of lymphocytes without necrotic keratinocytes, Civatte bodies, or Max-Joseph spaces and solar lentigo or seborrheic keratosis adjacent to the lesion, but with epidermal hyperplastic change (clinically scaly plaque) in cases of lymphomatoid keratosis. Conventional histopathologic study as well as immunohistochemical examinations for CD1a, CD3, CD4, CD8, CD20, and CD79a and S100 protein and genotypic examinations were performed.

Setting  University departments comprising 2 sections of dermatology and 1 section of pathology.

Main Outcome Measures  Ratio of T to B cells and of CD4+ to CD8+ cells, and the phenotype of epidermotropic cells were evaluated. Gene rearrangement of the immunoglobulin heavy chain gene and T-cell receptor (TCR)-β and TCR{gamma} genes was also investigated by the polymerase chain reaction method.

Results  Immunohistochemically, epidermotropic CD20+ and/or CD79a+ cells were present. In the upper dermal lymphocytic infiltrates, the CD3+/CD79a+ cell ratio ranged from 5:5 to 8:2. The CD4+/CD8+ cell ratio was within normal limits. Rearrangements of the TCR{gamma} gene were demonstrated in 2 cases and of the TCRβ gene in 1 case.

Conclusions  Our results indicate that lymphomatoid keratosis is a clinically benign keratotic lesion but histologically malignant, simulating mycosis fungoides. Immunohistochemical findings showed a reaction pattern in all cases, but genotypical examination showed some clonal dermatoses. Therefore, "lymphomatoid" keratosis should be classed as a pseudolymphoma, namely, a subtype of cutaneous lymphoid hyperplasia with epidermotropism.


Author Affiliations: Departments of Pathology (Drs Arai, Shimizu, Ogawa, and Hirose) and Dermatology (Dr Tsuchida), and Department of Dermatology, Saitama Medical Center (Dr Izaki), Saitama Medical University, Saitama, Japan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.